Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.36
+0.02 (+1.49%)
Range 1.28 - 1.38
Open 1.32
Prev Close 1.34
52 Week 1.25 - 3.18
Volume 1407868
Market Cap 700.2M
*Delayed 9/23/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000